Tag: Bosentan

An estimated 192,000 people globally had pulmonary arterial hypertension (PAH) in 2021 [1.9.1]. For many, a key question is, **what is bosentan 62.5 mg used for?** This medication is a cornerstone therapy for managing this serious condition by improving exercise ability and slowing disease progression [1.2.1, 1.2.2].

First approved by the FDA in 2001, bosentan (Tracleer) is an oral medication that improves exercise capacity and slows disease progression in patients with pulmonary arterial hypertension (PAH). The medication is in a class known as endothelin receptor antagonists, and understanding what is bosentan used for requires delving into how it targets the root causes of these conditions.